Related Experiment Video
Updated: Apr 17, 2026
05:36
Subjective Refraction Test Using a Smartphone for Vision Screening
Published on: October 18, 2024
2.0K
Exploring medication use by blind patients in Saudi Arabia
Basma Y Kentab1, Kholuod Z Al-Rowiali2, Rehab A Al-Harbi2
1Clinical Pharmacy Department, College of Pharmacy, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia.
Summary
Blind patients face significant challenges with medication management, including drug identification and dose recognition. Improved pharmaceutical services are crucial to address these medication use problems.
Area of Science:
- Pharmacy
- Ophthalmology
- Public Health
Background:
- Medication management presents unique challenges for visually impaired individuals.
- Understanding these challenges is essential for improving patient care and safety.
Purpose of the Study:
- To investigate the medication use patterns and challenges faced by blind patients in Saudi Arabia.
- To identify areas for improvement in pharmaceutical services for this population.
Main Methods:
- A cross-sectional descriptive study was conducted with blind adults in Saudi Arabia.
- Data were collected using questionnaires administered in person and online.
Main Results:
- Most blind patients reported difficulties with drug identification, dose recognition, and identifying expiration dates.
- A significant number relied on sighted individuals for medication management.
- Physicians were perceived as the most reliable information source, while pharmacist services were deemed inadequate.
Conclusions:
- Current pharmaceutical services are inadequate for blind patients' needs.
- Collaboration between government, pharmaceutical companies, and pharmacists is necessary to develop targeted interventions.
- This study highlights the need for enhanced support and accessible medication information for the visually impaired.
More Related Videos
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
375
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
375
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
824
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
824
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
365
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
365
01:19Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
02:07Blind Procedures
13.9K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.9K
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
345
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
345